AK Medical Holdings (HKSE:01789) Cash-to-Debt : 8.63 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is AK Medical Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. AK Medical Holdings's cash to debt ratio for the quarter that ended in Dec. 2023 was 8.63.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, AK Medical Holdings could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for AK Medical Holdings's Cash-to-Debt or its related term are showing as below:

HKSE:01789' s Cash-to-Debt Range Over the Past 10 Years
Min: 8.63 Med: 262.22 Max: No Debt
Current: 8.63

During the past 10 years, AK Medical Holdings's highest Cash to Debt Ratio was No Debt. The lowest was 8.63. And the median was 262.22.

HKSE:01789's Cash-to-Debt is ranked better than
71.55% of 840 companies
in the Medical Devices & Instruments industry
Industry Median: 1.97 vs HKSE:01789: 8.63

AK Medical Holdings Cash-to-Debt Historical Data

The historical data trend for AK Medical Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

AK Medical Holdings Cash-to-Debt Chart

AK Medical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

41.38

33.58

20.24

26.88

8.63

AK Medical Holdings Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial													20.24	19.46	26.88	11.53	8.63

Competitive Comparison of AK Medical Holdings's Cash-to-Debt

For the Medical Devices subindustry, AK Medical Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AK Medical Holdings's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AK Medical Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where AK Medical Holdings's Cash-to-Debt falls into.

AK Medical Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

AK Medical Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	794.818	/	(38.975	+	53.125)
	=	8.63

AK Medical Holdings's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	794.818	/	(38.975	+	53.125)
	=	8.63

AK Medical Holdings (HKSE:01789) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

AK Medical Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of AK Medical Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

AK Medical Holdings (HKSE:01789) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AK Medical Holdings Ltd (HKSE:01789) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 10 Baifuquan Road, 2nd Floor, Xingye Mansion, Changping District Science and Technology Park, Beijing, CHN, 102200

Website

https://www.ak-medical.net/index.html

AK Medical Holdings Ltd is an investment holding company which designs, develops, produces, and markets orthopedic joint implants and related products. The company's geographical segments include China and the United Kingdom. It derives the majority of revenue from China. The company offers off-the-shelf products, such as knee replacement and hip replacement implants; and 3D-printed products, including 3D-printed hip replacement implants, spinal interbody cages, and artificial vertebral bodies.

Executives

Li Zhijiang
Trident Trust Company (hk) Limited
Ximalaya Limited
The Goldman Sachs Group, Inc.	2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd.	2102 Investment manager
Suntop Limited	2101 Beneficial owner
Zhang Chaoyang	2307 Founder of a discretionary trust who can infl
Bamboo Group Management Limited	2201 Interest of corporation controlled by you
Zhang Bin	2202 Interest of your spouse
Rainbow Holdings Limited	2201 Interest of corporation controlled by you
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner
Orbimed Advisors Ii Limited
Orbimed Asia Gp Ii, L.p.
Orbimed Asia Partners Ii, L.p.

AK Medical Holdings (HKSE:01789) Headlines

No Headlines